|
Ligand ID | 5O2 |
InChI | InChI=1S/C41H42N8/c42-29-18-20-32-33-21-19-30(43)26-39(33)49(41(36(32)25-29)28-11-3-1-4-12-28)23-10-2-5-13-31-27-48(47-46-31)24-22-44-40-34-14-6-8-16-37(34)45-38-17-9-7-15-35(38)40/h1,3-4,6,8,11-12,14,16,18-21,25-27,43H,2,5,7,9-10,13,15,17,22-24,42H2,(H,44,45)/p+1 |
InChIKey | XIORYVGXAQRYQA-UHFFFAOYSA-O |
SMILES | Software | SMILES |
---|
OpenEye OEToolkits 2.0.4 | c1ccc(cc1)c2c3cc(ccc3c4ccc(cc4[n+]2CCCCCc5cn(nn5)CCNc6c7ccccc7nc8c6CCCC8)N)N | CACTVS 3.385 | Nc1ccc2c3ccc(N)cc3[n+](CCCCCc4cn(CCNc5c6CCCCc6nc7ccccc57)nn4)c(c8ccccc8)c2c1 |
|
Formula | C41 H43 N8 |
Name | 6-phenyl-5-[5-[1-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]-1,2,3-triazol-4-yl]pentyl]phenanthridin-5-ium-3,8-diamine; anti TZ2PA5 |
ChEMBL | |
DrugBank | |
ZINC | ZINC000162602401
|
PDB chain | 5ehq Chain A Residue 1504
[Download ligand structure]
[Download structure with residue number starting from 1]
[View ligand structure]
|
|
|